Direct supply and contract verification protocols designed to meet Saudi Food and Drug Authority (SFDA) requirements, accelerating clinical trial data validation and active ingredient analysis.
The Kingdom of Saudi Arabia (KSA) is undergoing a major bio-industrial transformation under the framework of Saudi Vision 2030. As Riyadh and Jeddah position themselves as life-science hubs across the Middle East, the domestic pharmaceutical, dietary supplement, and therapeutic herbal sectors face increased regulatory oversight. The Saudi Food and Drug Authority (SFDA) mandates strict chemical qualification, active biomarker quantification, pesticide threshold screenings, and thermal stability profiles under high ambient temperatures (Zone IVb conditions). In this landscape, establishing reliable, reproducible, and internationally defensible analysis methods is essential for commercial market authorization.
Analytical method establishment is not merely a laboratory procedure; it is the regulatory backbone that confirms identity, purity, potency, and safety of bioactive ingredients. Whether dealing with indigenous Arabian flora such as Commiphora gileadensis and date palm pollen extracts, or standardized botanical therapeutics imported into the Gulf Cooperation Council (GCC), domestic enterprises face significant bottlenecks in high-throughput chromatography, chiral resolution, and mass spectrometry profiling.
While Saudi Arabia’s localized healthcare clusters develop, partnering with established Chinese CRO and CDMO powerhouses offers a tangible competitive advantage. China’s bio-analytical infrastructure benefits from deep botanical compound libraries, automated LC-MS/MS and GC-MS hardware, and large teams of natural chemistry doctorates. Chinese manufacturing platforms resolve raw material yield challenges through advanced flash column chromatography and macroporous resin separation techniques, delivering cost-efficient, high-precision methods directly configured to match SFDA registration dossiers.
For Saudi procurement directors and R&D executives, this cross-border integration shortens method development timelines from 18 months down to several weeks. Full raw data integration, validation summaries aligned with ICH Q2(R1) guidelines, and validation for specificity, linearity, range, accuracy, precision, and robustness ensure fast market registration across Saudi healthcare portals.
Combining traditional medicine know-how with modern separation science to establish clear quality baselines.
Reversed-phase, ion-exchange, and hydrophilic interaction chromatography (HILIC) method development for the accurate assay of low-concentration phytoceutical markers, active pharmaceutical ingredients (APIs), and complex multi-component botanicals.
High-Performance Thin-Layer Chromatography method setup offering reproducible optical scanning, Rf tracking, and multi-wavelength derivatization to confirm plant identity, prevent species adulteration, and satisfy Pharmacopoeia requirements.
Gas chromatography systems paired with flame ionization (FID) and mass spectrometry (MS) detection, engineered to profile essential oils, aroma actives, residual solvents, and volatile fatty acid compositions.
Complete statistical evaluation of analytical validation criteria: System Suitability, Specificity against degradation matrices, Linearity (R² > 0.999), Precision (Repeatability and Intermediate Precision RSD < 2.0%), and Method Transfer robustness.
Forced degradation profiling (thermal stress, acid/base hydrolysis, photolysis, and oxidative breakdown) to prove that the analytical assay accurately monitors target molecules without interference from degradation products.
Systematic recovery optimization evaluating microwave-assisted, ultrasonic, and supercritical fluid extraction techniques to achieve >98% active ingredient release without thermal compound breakdown.
From local contract formulation to clinical trial submissions, standard analytical practices are changing.
Saudi universities and research centres are investigating native plants (e.g., Sidr, Moringa peregrina, frankincense) for commercial therapeutic use. Establishing reproducible chromatographic fingerprint methods supports local IP monetization and reliable clinical trials.
Brand owners importing dietary supplements, functional beverages, and herbal extracts into Saudi Arabia require analytical documentation. We generate Certificates of Analysis and validated test methods that comply with SFDA and Saudi Standards (SASO) expectations.
The Gulf personal care market demands high purity for bio-derived skincare formulations. We establish quantification methods for polyphenols, flavonoids, and organic acids to ensure batch-to-batch consistency and claim substantiation.
Review our core pipeline options, spanning initial molecule screening to large-scale clinical trials and analytical method verification.
Straightforward answers regarding compliance, method transfers, and supply chain logistics.
Partner with an established natural medicine CRO/CDMO. Whether you require custom method establishment, bioactive compound extraction, or clinical safety validation, our team is ready to assist.
Send Inquiry Now